AbCellera Biologics Inc. — Company profile
Healthcare · Biotechnology · Canada
Last price 12.27 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.98B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Details
| Name | AbCellera Biologics Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 562 |
| Founded | 2012 |
| Ipo Date | 2020-12-11 |
| Ceo | Carl Hansen |
| Country | Canada |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 20.00 |
| Isin | CA00288U1066 |
| Cusip | 00288U106 |
| Cik | 1703057 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Dr. Carl L.G. Hansen Ph.D. | Chief Executive Officer, President and Chairperson |
| Andrew Booth M.B.A. | Chief Financial Officer |
| Dr. Veronique Lecault Ph.D. | Chief Technology Officer and Director |
| Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer |
| Andrew Knowles M.Sc. | Vice President of Operations |
| Martin Hogan M.Sc. | Senior Director of Strategic Finance and IR |
| Tiffany Chiu B.Sc., Ph.D. | Vice President of Communications |
Contact
| Address | 150 W 4th Avenue, Vancouver, BC V5Y 1G6, Canada |
| Phone | 604 559 9005 |
| Website | https://www.abcellera.com |